Furthermore, a notable interaction between p.Asn318Ser and insulin resistance was observed in normoglycemic individuals, suggesting that dyslipidemia is more severe in p.Asn318Ser carriers with decreased insulin sensitivity. Here, INS is linked to metabolic syndrome.